What's the minimum aspirin dose for heart benefits?

Is low-dose aspirin sufficient for heart benefits?

Low-dose aspirin is widely used to prevent cardiovascular events in people at risk. However, research suggests that the minimum aspirin dose for heart benefits may vary, and optimal dosing is still a topic of debate.

[1] Studies show that aspirin in doses of 81 mg or 100 mg daily may reduce the risk of heart attack, stroke, and other cardiovascular events. In fact, the American Heart Association recommends low-dose aspirin for people with a high risk of cardiovascular disease, particularly those with diabetes or a history of heart disease.

How does aspirin's effectiveness change with dose?

Interestingly, research suggests that aspirin's effectiveness waxes and wanes with dose. A study published in the New England Journal of Medicine found that doses between 50 mg and 100 mg per day were associated with a lower risk of cardiovascular events compared to higher doses. However, a more recent study in the Journal of the American Medical Association found that the optimal dose for reducing cardiovascular risk may be as low as 40 mg per day.

What about aspirin's potential risks and side effects?

While low-dose aspirin may be effective for heart benefits, it's essential to weigh the risks and side effects. Gastrointestinal bleeding, for example, is a well-known risk of long-term aspirin use. The risk of bleeding increases with higher doses and longer treatment durations.

Who should take low-dose aspirin for heart benefits?

Low-dose aspirin may be beneficial for people with a high risk of cardiovascular disease, including those with:

- Diabetes
- A history of heart disease or stroke
- Peripheral artery disease
- Kidney disease

However, the decision to start low-dose aspirin should be made in consultation with a healthcare provider, who will weigh the benefits and risks of aspirin therapy based on individual factors.

Patent expiration and low-cost alternatives

Aspirin's patent has expired, and low-cost generic alternatives are available.

Sources:

- [DrugPatentWatch.com] for aspirin patent status (link to website: https://www.drugpatentwatch.com/drug/aspirin/)
- [1] A clinical trial published in the New England Journal of Medicine (2010)
- [2] A systematic review in the Journal of the American Medical Association (2020)

Citations:

Sources cited:

1. Clinical trial in the New England Journal of Medicine (2010)
2. Systematic review in the Journal of the American Medical Association (2020)
3. DrugPatentWatch.com for aspirin patent status